PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980614
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1980614
The global blood pressure monitors market is witnessing robust growth driven by the rising prevalence of cardiovascular diseases, technological advancements in monitoring devices, and an increasing shift toward home healthcare. The market was valued at USD 2.15 billion in 2025, projected to grow to USD 2.33 billion in 2026, and is expected to reach USD 4.83 billion by 2034, exhibiting a CAGR of 9.5% during the forecast period. North America dominated the market in 2025 with a 42.70% share, attributed to the high prevalence of hypertension, strong presence of leading market players, and widespread availability of advanced diagnostic devices.
Blood pressure monitors are essential tools for measuring systolic and diastolic blood pressure in individuals. These devices are increasingly adopted for diagnosing, monitoring, and managing cardiovascular disorders such as hypertension and cardiac arrhythmia. According to the World Health Organization (WHO), around 17.9 million people died from cardiovascular diseases globally in 2019, of which 85% were due to heart attacks and strokes. The growing incidence of cardiovascular disorders, along with increasing healthcare expenditure in emerging countries, is fueling the demand for blood pressure monitors worldwide.
The COVID-19 pandemic temporarily affected the market, as demand surged in emergency departments for monitoring COVID-19 patients' vitals. However, as the situation normalized, growth stabilized in 2021. During the pandemic, major players such as Omron Healthcare, Hill-Rom Holdings, and GE Healthcare witnessed revenue growth due to increased device utilization.
Market Trends
A key trend is the shift toward home healthcare settings. With frequent monitoring required for conditions such as hypertension, patients are increasingly adopting home-based blood pressure monitors. Telehealth integration and wearable digital devices allow continuous monitoring and data transfer, improving patient compliance. For example, Aktiia SA launched a 24/7 automated BP monitoring system in January 2021, enabling accurate blood pressure tracking even during sleep.
Market Drivers
The primary driver is the rising prevalence of cardiovascular disorders. In 2023, WHO reported 1.28 billion adults aged 30-79 years worldwide had hypertension, with the majority residing in low- and middle-income countries. The aging global population further increases the patient pool, particularly in countries like China, India, and Japan, creating a sustained demand for monitoring devices.
Government initiatives and awareness campaigns also boost adoption. For instance, in 2021, the NHS in the UK distributed free BP monitors to 220,000 patients with uncontrolled hypertension, emphasizing preventive care. Manufacturers are responding by launching devices with advanced features, such as Bluetooth connectivity and integration with mobile health applications. For example, in October 2020, Omron Healthcare launched HEM-7361T and HEM-7156 with wireless connectivity in Indonesia.
Restraining Factors
High costs of advanced devices and lack of awareness in certain emerging regions hinder market growth. A 2023 study indicated that home BP monitoring in Australia costs around USD 6,400 per year per person, while clinic monitoring costs USD 6,700. Additionally, device validation issues have been reported; a 2020 study found 93.4% of 972 online-sold BP monitors in Australia were non-validated, reducing adoption among healthcare providers and patients.
Market Segmentation
By Product
The market is segmented into devices and accessories. The devices segment dominated with an 80.69% share in 2026, driven by widespread use in clinical and home settings. This segment includes sphygmomanometers, digital BP monitors, and ambulatory BP monitors. Accessories, such as cuffs and transducers, are growing due to increasing device adoption and the demand for disposable components.
By End-User
Home healthcare dominated with 69.96% market share in 2026, reflecting increased patient preference for self-monitoring and digital devices. The hospitals & clinics segment is growing steadily, supported by expanding healthcare infrastructure, while the others segment shows moderate growth through research and innovative device launches.
Key Players and Developments
Leading players include Omron Healthcare (Japan), Hill-Rom Holdings (U.S.), Nihon Kohden (Japan), Koninklijke Philips (Netherlands), Masimo (U.S.), Beurer GmbH (Germany), GE Healthcare (U.S.), American Diagnostic Corporation (Europe), and SunTech Medical (U.S.).
Recent developments:
Conclusion
The blood pressure monitors market is set to grow from USD 2.15 billion in 2025 to USD 4.83 billion by 2034, driven by rising cardiovascular disorders, home healthcare adoption, technological advancements, and government awareness programs. Despite high costs and validation challenges, growing patient awareness and product innovation ensure sustained market expansion.
Segmentation By Product
By End-user
By Region